Utah Medical Products Q1 profit drops on lost China and OEM sales

Utah Medical Products

23/04/2026 14:10

Overview

U.S. medical device maker's Q1 sales fell 10.2% yr/yr due to lost China and OEM sales

Q1 net income dropped 14.4% yr/yr, EPS declined 11.0%

Company repurchased 2,196 shares in Q1, supporting EPS despite lower net income

Outlook

Company expects 2026 litigation expenses to be lower than 2025, barring trial cases

Utah Medical Products anticipates 2026 U.S. health care costs to normalize after Q1 spike

Result Drivers

LOSS OF CHINA AND OEM SALES - Co said absence of sales to former China distributor and OEM customer PendoTECH accounted for most of the yr/yr sales decline

HIGHER OPERATING EXPENSES - Increased litigation and U.S. employee healthcare costs drove operating expenses higher

FAVORABLE PRODUCT MIX - Gross profit margin improved due to absence of low-margin China sales and a one-time inventory adjustment

Company press release: ID:nACS7jcTPa

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Sales
$8.72 mln
Q1 EPS
$0.82
Q1 Net Income
$2.60 mln


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)